We proudly present the first publication by a user project which received our PRISMAP services. 

Outcomes of the project entitled "Added Value using Terbium-161 over Lutetium-177 in Combination with the metabolically more stable GRPR Ligand AMTG for Targeted Radiotherapy of GRPR-expressing Malignancies? – A Preclinical Evaluation", led by Dr. rer. nat. Thomas Günther from Technical University of Munich, Germany have just been published in JNM. 

Enjoy reading!